A new study found zero relapses among patients given a new treatment regime, with far better results than would be expected ...
Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely ...
As colorectal cancer rates rise among young people, most patients with advanced disease still only have one treatment option: ...
A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
The cancer was a very obvious lump high up in my bowel. I was told it was at stage three, and later learned that it could ...
Switching from IV to subcutaneous injection eases hard vein access, cuts clinic time, and boosts comfort with faster ...
The management of cutaneous squamous cell carcinoma (CSCC) is undergoing a notable shift, with systemic immunotherapy playing ...
A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung cancer ...
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that a recent clinical case report on its self-developed novel Nectin-4 ADC ...
Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of ...
Treating some bowel cancer patients with immunotherapy before surgery improves survival and cuts the need for chemotherapy, ...
This segment highlights the role of clinical guidelines in shaping treatment decisions in advanced melanoma, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results